BGM0504
A Study Comparing the Effects of BGM0504 Injection and Semaglutide Injection on Obese Subjects.
BrightGene Bio-Medical Technology Co · Phase 2 · Completed · Enrollment 60
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Semaglutide | n/r | n/r | n/r | n/r | n/r |
| BGM0504 | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.